Case Studies

Healthcare and pharma Competitive Intelligence dashboard

Posted by | Fuld & Company

A US-based healthcare company wanted to explore its options for a clinical drug development strategy that would minimize its time to market. It therefore sought to keep track of all the drug developments in its therapeutic areas to identify key industry learnings.

Objective

To track and analyze all the drug trials and pipelines in their priority therapeutic areas.

Solution

Pipeline overview across regions and pain segments

Dynamic dashboard with key analyses and timelines

  • Worked with the client to understand key analysis requirements and functionalities in terms of drill-downs.
  • Information was collated from various drug, clinical trial, and financial databases, including ClinicalTrials.gov, BCIQ, Global Data, Cortellis, Capital IQ, and Bloomberg.
  • Automated data pipelines and ingestion workflows to automate data refresh were created.
  • Various design wireframes were tested in collaboration with the client.
  • A dynamic dashboard with key analyses and timelines for drug trials and discovery was created.

Outcome

  • The dashboard enabled the company to stay updated on key developments related to its therapeutic areas.
  • Gaps and white spaces that could be monetized were identified.

Tools

Tags: , , , , ,

Related Resources

Read More

A strategic roadmap for evolving customer expectations

Fuld & Company partnered with a leading fuel retailer to develop a comprehensive strategic roadmap aimed at improving dealer retention, […]

Read More

Tailored investment thesis drives PE firm’s dominance in $2 billion verticals

Objective  A Private Equity firm with ~$1.5 billion in AUM, specializing in technology, consumer and healthcare sectors, approached Fuld to […]

Read More

Strategic support drives climate tech success for private equity firm

Objective  A Private Equity (PE) firm sought to expand its presence in the growing North American climate tech market. The […]

Subscribe to our mailing list for our latest updates:

Subscribe Now